High systolic
Pro Research Analysisby 
Searched over 200M research papers for "high systolic"
The Impact of High Systolic Blood Pressure on Health Outcomes
Elevated Systolic Blood Pressure and Cardiovascular Risk
Elevated systolic blood pressure (SBP) is a significant risk factor for cardiovascular diseases (CVD) and renal diseases. Research indicates that the relationship between SBP and the risk of coronary heart disease, stroke, and end-stage renal disease is continuous, graded, and independent of diastolic blood pressure (DBP) . Studies have shown that a reduction of 12 to 13 mm Hg in SBP over four years can lead to a 21% reduction in coronary heart disease, a 37% reduction in stroke, a 25% reduction in total cardiovascular mortality, and a 13% reduction in all-cause mortality .
Systolic Blood Pressure Targets in Older Adults
The 2014 Eighth Joint National Committee (JNC-8) recommended a systolic BP target of <150 mm Hg for individuals aged 60 years or older, a shift from the previous target of <140 mm Hg. However, evidence suggests that achieving a BP target of <140 mm Hg is associated with better outcomes in hypertensive patients with coronary artery disease (CAD) aged 60 years or older. These patients had lower rates of all-cause mortality, cardiovascular mortality, myocardial infarction, and stroke compared to those with higher BP targets . This indicates that a more aggressive BP target may be beneficial for older adults with high cardiovascular risk.
Gender Differences in Hypertension Risk
High-normal systolic BP in early midlife is a stronger predictor of incident hypertension later in life for women than for men. Women with high-normal systolic BP (130-139 mm Hg) at baseline were found to have a significantly higher risk of developing hypertension compared to men . This suggests that women may benefit from earlier and more aggressive management of systolic BP to prevent future hypertension.
Systolic Blood Pressure and Cardiovascular Events in Women
In women with heart disease or multiple risk factors, high systolic BP significantly increases the risk of cardiovascular events. For each 10-mm Hg increase in systolic BP, there is a 9% increase in the risk of cardiovascular events, including nonfatal myocardial infarction, nonfatal stroke, and cardiovascular disease death . This highlights the importance of managing systolic BP to reduce cardiovascular risk in women.
Optimal Systolic Blood Pressure Targets
The Systolic Blood Pressure Intervention Trial (SPRINT) aims to determine the optimal systolic BP target to reduce adverse health outcomes. The trial compares a standard target of <140 mm Hg with a more intensive target of <120 mm Hg in high-risk individuals, including those with cardiovascular disease, chronic kidney disease, and older adults . Preliminary findings suggest that intensive BP control may offer additional benefits in reducing cardiovascular events and mortality.
Conclusion
High systolic blood pressure is a critical factor in the development of cardiovascular and renal diseases. Evidence supports the need for aggressive management of systolic BP, particularly in older adults and women, to reduce the risk of adverse health outcomes. Ongoing research, such as the SPRINT trial, will further clarify the optimal BP targets to improve patient outcomes.
Sources and full results
Most relevant research papers on this topic